Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Neoplasms, Squamous Cell 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 2Cisplatin 2Cetuximab 2zalutumumab 1poly ICLC 1enzalutamide 1abemaciclib 1Radiotherapy 1Papanicolaou Test 1Oxaliplatin 1Neoadjuvant Therapy 1Injections, Subcutaneous 1Human Papillomavirus DNA Tests 1High-Intensity Focused Ultrasound Ablation 1Gemcitabine 1Fluorouracil 1Everolimus 1Docetaxel 1Colposcopy 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms, Squamous Cell × zalutumumab × Clear all
NCT00401401 2011-12-23

Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer

Genmab

Phase 1/2 Terminated
30 enrolled 13 charts
Head & Neck

Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡